IL4I1-driven AHR signature: a new avenue for cancer therapy
Main Authors: | Zuli Wang, Tiansheng Li, Chao Mao, Wenliang Liu, Yongguang Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00529-z |
Similar Items
-
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
by: Tiansheng Li, et al.
Published: (2020-10-01) -
A new insight into the role of aryl hydrocarbon receptor (AhR) in the migration of glioblastoma by AhR-IL24 axis regulation
by: Yiyun Liu, et al.
Published: (2021-09-01) -
What role for AHR activation in IL4I1-mediated immunosuppression ?
by: Flavia Castellano, et al.
Published: (2021-01-01) -
New Avenues for Nanoparticle-Related Therapies
by: Michael Zhao, et al.
Published: (2018-05-01) -
AHR Signaling Dampens Inflammatory Signature in Neonatal Skin γδ T Cells
by: Katja Merches, et al.
Published: (2020-03-01)